Cite
HARVARD Citation
Otake, K. et al. (2016). Identification of DDX39A as a Potential Biomarker for Unfavorable Neuroblastoma Using a Proteomic Approach. Pediatric blood & cancer. 63 (2), pp. 221-227. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Otake, K. et al. (2016). Identification of DDX39A as a Potential Biomarker for Unfavorable Neuroblastoma Using a Proteomic Approach. Pediatric blood & cancer. 63 (2), pp. 221-227. [Online].